Please login to the form below

What to Consider When Conducting Patient Research in Saudi Arabia

The need to understand the patient as a key stakeholder is now recognized by pharma across the globe.

Conducting market research with patients in any market can be a challenge, requiring sensitivity and consideration for language, culture, religion, as well as for other emotional, behavioural and environmental factors that might impact patients’ behaviour.

In The Kingdom of Saudi Arabia (KSA), where religion and culture are central to society and there are strict laws governing behaviour, patient research can be uniquely challenging. However, as the fastest growing pharma market in the Middle East, it is critical that those who want to leverage opportunities in this Arab state understand patient needs and behaviour. In this article, we will outline the factors to consider when designing a patient research programme, based on our experience and knowledge of the region.

Find out more:

9th February 2016



Company Details

Research Partnership

+44 (0)20 8069 5000

Contact Website

Chester House
Fulham Green
81-83 Fulham High Street
United Kingdom

Latest content on this profile

Virtual Conference Live
Research Partnership
Digital Health Tools - Physician Trends
Research Partnership
Live webinar:
Oncology landscape: How innovative market research methods can navigate you to success
Research Partnership
The disparity of patient experiences with Crohn’s Disease in Europe and Japan
Research Partnership
Research Partnership’s MedTech Division appoints two Directors
Chris Carles has joined as a Director in our Philadelphia office and Andrew Way as a Research Director in our UK office.
Research Partnership
Webcast: Influencing HCP behaviours – Is now the perfect opportunity?
Putting behavioural science at the forefront of market research
Research Partnership